Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 83,807 | 29,497 | 3,597 | 3,662 | 0 |
| Cost of Goods | 89,380 | 33,527 | 10,077 | 38,857 | N/A |
| Gross Profit | -5,573 | -4,030 | -6,480 | -35,195 | N/A |
| Operating Expenses | 265,268 | 240,759 | 243,782 | 556,573 | 559,259 |
| Operating Income | -270,461 | -244,262 | -250,185 | -590,911 | -559,259 |
| Interest Expense | 22,579 | 16,353 | 6,322 | 0 | 0 |
| Other Income | 52,395 | 48,576 | 26,282 | 28,531 | -1,111 |
| Pre-tax Income | -240,645 | -212,039 | -230,225 | -562,380 | -560,370 |
| Income Tax | 70 | -126 | 117 | 258 | 686 |
| Net Income Continuous | -240,715 | -211,913 | -230,342 | -562,638 | -561,056 |
| Net Income Discontinuous | N/A | N/A | N/A | -256,740 | -57,639 |
| Net Income | $-240,715 | $-211,913 | $-230,342 | $-819,378 | $-618,695 |
| EPS Basic Total Ops | -24.84 | -38.59 | -58.60 | -237.80 | -199.00 |
| EPS Basic Continuous Ops | -24.84 | -38.59 | -58.62 | -163.20 | -180.40 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -74.60 | -18.60 |
| EPS Diluted Total Ops | -24.84 | -38.59 | -58.60 | -237.80 | -199.00 |
| EPS Diluted Continuous Ops | -24.84 | -38.59 | -58.62 | -163.20 | -180.40 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -74.60 | -18.60 |
| EPS Diluted Before Non-Recurring Items | -24.84 | -38.60 | -66.00 | -157.20 | -199.00 |
| EBITDA(a) | $-209,217 | $-215,737 | $-241,841 | $-571,262 | $-539,903 |